MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$8,057K
(64.86%↑ Y/Y)
Net loss
-$8,057K
(64.86%↑ Y/Y)
Net loss before
income taxes
-$8,057K
(64.86%↑ Y/Y)
Interest income and other
income, net
$83K
(-88.36%↓ Y/Y)
Manufacture And Supply
Revenue
$8,793K
(22.24%↑ Y/Y)
License And Royalty
Revenue
$5,395K
(582.91%↑ Y/Y)
Co Development And
Research Fees
$258K
(-38.28%↓ Y/Y)
Loss from operations
-$4,204K
(78.29%↑ Y/Y)
Interest expense
$2,903K
(4.35%↑ Y/Y)
Interest expense related
to royalty...
$973K
(-32.29%↓ Y/Y)
Revenues
$14,446K
(65.67%↑ Y/Y)
Interest expense related
to the sale of...
$60K
(1.69%↑ Y/Y)
Total costs and
expenses
$18,650K
(-33.59%↓ Y/Y)
Selling, general and
administrative
$10,977K
(-42.44%↓ Y/Y)
Research and development
$4,204K
(-21.58%↓ Y/Y)
Manufacture and supply
$3,469K
(-5.01%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST)